Cite
HARVARD Citation
Prieto-González, S. et al. (2017). Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients. RMD open. 3 (2), p. . [Online].